Meropenem-Induced Facial Myoclonus.

Millar Vernetti, Patricio; Dalamo, Kaia; Khan, Zenith; Gonzalez-Duarte, Alejandra; Frucht, Steven; Kaufmann, Horacio

Millar Vernetti, Patricio; Dalamo, Kaia; Khan, Zenith; Gonzalez-Duarte, Alejandra; Frucht, Steven; Kaufmann, Horacio.

Afiliación

Millar Vernetti P; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Dalamo K; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Khan Z; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Gonzalez-Duarte A; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Frucht S; Department of Neurology Fresco Institute for Parkinson's and Movement Disorders New York University Grossman School of Medicine New York New York USA.
Kaufmann H; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.

Mov Disord Clin Pract ; 10(Suppl 3): S21-S23, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37636233

Palabras clave

carbapenems; myoclonus; neurotoxicity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mov Disord Clin Pract Año: 2023 Tipo del documento: Article